Drug Trial Radar · NCT00235716
A Randomized, Clinical Trial of Vitamin E and Memantine in Alzheimer's Disease
Last checked: Nov 20, 2026Latest source record: Jul 23, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
613
Actual
Start
Aug 2007
Primary completion
Sep 2012
Study completion Oct 2012
Sponsor
- Lead sponsor
- US Department of Veterans AffairsFederal agency
- Sponsor type
- Federal agency
- Collaborators
- Forest Laboratories; dsm-firmenich Switzerland AG
- First posted
- Oct 10, 2005
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Factorial
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- Who can join
- All sexes, from 40 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to determine whether alpha-tocopherol, memantine (Namenda), or the combination will significantly delay clinical progression in mild to moderately demented patients with Alzheimer's disease compared to placebo.
Conditions
- Alzheimer's Disease
Interventions
dl-alpha-tocopherolDrug
Alpha-tocopherol will be given as an oral dose of 1000 IU twice a day (morning and evening). The form of vitamin E that will be used in this study will be hard gel capsules of dl-alpha-tocopheryl acetate ("synthetic") vitamin E.
MemantineDrug
A moderate-affinity NMDA antagonist. Memantine will be titrated over four weeks to a maintenance dose of 10 mg twice a day. During week 1 patients will take one 5-mg memantine tablet in the morning. During week 2 patients will take one 5-mg memantine tablet in the morning and one in the evening. During week 3 patients will take two 5-mg memantine tablets in the morning and one 5-mg tablet in the evening. Beginning with week 4, participants will take four 5-mg tablets daily, two in the morning and two in the evening.
dl-alpha-tocopherolDrug
Alpha-tocopherol will be given as an oral dose of 1000 IU twice a day (morning and evening). The form of vitamin E that will be used in this study will be hard gel capsules of dl-alpha-tocopheryl acetate ("synthetic") vitamin E.
MemantineDrug
A moderate-affinity NMDA antagonist. Memantine will be titrated over four weeks to a maintenance dose of 10 mg twice a day. During week 1 patients will take one 5-mg memantine tablet in the morning. During week 2 patients will take one 5-mg memantine tablet in the morning and one in the evening. During week 3 patients will take two 5-mg memantine tablets in the morning and one 5-mg tablet in the evening. Beginning with week 4, participants will take four 5-mg tablets daily, two in the morning and two in the evening.
PlaceboDrug
Matching placebos for dl-alpha-tocopherol and memantine.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Alzheimer's Disease Cooperative Study/Activities of Daily Living (ADCS/ADL) Inventory Change From BaselineTime frame: 6, 12, 18, 24, 30, 36, 42 and 48 months minus baseline
- Mini-Mental State Examination Change From BaselineTime frame: 6, 12, 18, 24, 30, 36, 42 and 48 months minus baseline
- Alzheimer's Disease Assessment Scale - Cognitive (ADAS-cog) Change From BaselineTime frame: 6, 12, 18, 24, 30, 36, 42 and 48 months minus baseline
- Neuropsychiatric Inventory Change From BaselineTime frame: 6, 12, 18, 24, 30, 36, 42 and 48 months minus baseline
- Caregiver Activity Survey Change From BaselineTime frame: 6, 12, 18, 24, 30, 36, 42 and 48 months minus baseline
Locations
14 sites in 2 countries. Site status is shown where the registry gives one.
VA Medical Center, Bay Pines
Bay Pines, Florida
VA Medical Center, Miami
Miami, Florida
VA Medical Center, Iowa City
Iowa City, Iowa
VA Maryland Health Care System, Baltimore
Baltimore, Maryland
VA Medical Center, Jamaica Plain Campus
Boston, Massachusetts
VA Ann Arbor Healthcare System
Ann Arbor, Michigan
VA Medical Center, Minneapolis
Minneapolis, Minnesota
Salisbury VAMC
Salisbury, North Carolina
VA Medical Center, Cleveland
Cleveland, Ohio
Ralph H Johnson VA Medical Center, Charleston
Charleston, South Carolina
VA North Texas Health Care System, Dallas
Dallas, Texas
VA Puget Sound Health Care System, Seattle
Seattle, Washington
Wlliam S. Middleton Memorial Veterans Hospital, Madison
Madison, Wisconsin
VA Medical Center, San Juan
San Juan, Puerto Rico
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.